Kayne Anderson Rudnick Investment Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10
| Closed | -$296 | – | 786 |
|
|
2022
Q4 | $296 | Sell |
10
-2
| -17% | -$59 | ﹤0.01% | 670 |
|
|
2022
Q3 | $0 | Sell |
12
-108,938
| -100% | – | ﹤0.01% | 643 |
|
|
2022
Q2 | $2.43M | Sell |
108,950
-1,303,309
| -92% | -$29.1M | 0.01% | 310 |
|
|
2022
Q1 | $35.5M | Sell |
1,412,259
-54,504
| -4% | -$1.37M | 0.09% | 157 |
|
|
2021
Q4 | $52.6M | Buy |
1,466,763
+11,170
| +0.8% | +$400K | 0.12% | 148 |
|
|
2021
Q3 | $62M | Buy |
1,455,593
+6,151
| +0.4% | +$262K | 0.15% | 134 |
|
|
2021
Q2 | $62.7M | Buy |
1,449,442
+228,201
| +19% | +$9.88M | 0.15% | 133 |
|
|
2021
Q1 | $49.8M | Sell |
1,221,241
-325,019
| -21% | -$13.3M | 0.13% | 141 |
|
|
2020
Q4 | $70M | Buy |
1,546,260
+54,650
| +4% | +$2.47M | 0.2% | 117 |
|
|
2020
Q3 | $52.8M | Buy |
1,491,610
+93,827
| +7% | +$3.32M | 0.19% | 114 |
|
|
2020
Q2 | $52.1M | Buy |
1,397,783
+70,386
| +5% | +$2.62M | 0.22% | 103 |
|
|
2020
Q1 | $38.4M | Sell |
1,327,397
-7,082
| -0.5% | -$205K | 0.22% | 97 |
|
|
2019
Q4 | $69.2M | Sell |
1,334,479
-9,711
| -0.7% | -$504K | 0.33% | 83 |
|
|
2019
Q3 | $73.8M | Sell |
1,344,190
-283,444
| -17% | -$15.6M | 0.38% | 70 |
|
|
2019
Q2 | $66.1M | Buy |
1,627,634
+34,313
| +2% | +$1.39M | 0.35% | 73 |
|
|
2019
Q1 | $48.2M | Buy |
1,593,321
+174,716
| +12% | +$5.28M | 0.28% | 86 |
|
|
2018
Q4 | $47.7M | Sell |
1,418,605
-129,911
| -8% | -$4.37M | 0.33% | 78 |
|
|
2018
Q3 | $65.3M | Sell |
1,548,516
-51,657
| -3% | -$2.18M | 0.38% | 69 |
|
|
2018
Q2 | $51.2M | Sell |
1,600,173
-107,152
| -6% | -$3.43M | 0.33% | 83 |
|
|
2018
Q1 | $84.9M | Buy |
1,707,325
+40,115
| +2% | +$1.99M | 0.64% | 43 |
|
|
2017
Q4 | $89.9M | Buy |
1,667,210
+10,292
| +0.6% | +$555K | 0.73% | 38 |
|
|
2017
Q3 | $96.1M | Buy |
1,656,918
+233,325
| +16% | +$13.5M | 0.87% | 34 |
|
|
2017
Q2 | $70.2M | Buy |
1,423,593
+88,418
| +7% | +$4.36M | 0.7% | 42 |
|
|
2017
Q1 | $58M | Buy |
1,335,175
+700,234
| +110% | +$30.4M | 0.63% | 44 |
|
|
2016
Q4 | $31.1M | Buy |
634,941
+345,675
| +120% | +$16.9M | 0.37% | 80 |
|
|
2016
Q3 | $13.8M | Sell |
289,266
-10,981
| -4% | -$525K | 0.17% | 157 |
|
|
2016
Q2 | $16.1M | Buy |
300,247
+14,097
| +5% | +$756K | 0.24% | 118 |
|
|
2016
Q1 | $12.8M | Sell |
286,150
-47,388
| -14% | -$2.12M | 0.21% | 132 |
|
|
2015
Q4 | $12.7M | Sell |
333,538
-7,453
| -2% | -$284K | 0.21% | 128 |
|
|
2015
Q3 | $10.9M | Buy |
+340,991
| New | +$10.9M | 0.18% | 133 |
|